The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 24, 2023
Filed:
Sep. 06, 2017
Applicant:
Pharmakea, Inc., San Diego, CA (US);
Inventors:
Gretchen Bain, San Diego, CA (US);
Jillian Frances Evans, San Diego, CA (US);
Deidre A. Mackenna, San Diego, CA (US);
John Howard Hutchinson, San Diego, CA (US);
Assignee:
PHARMAKEA, INC., San Diego, CA (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/4439 (2006.01); A61P 35/00 (2006.01); A61K 45/06 (2006.01); C07D 401/12 (2006.01); A61P 19/00 (2006.01); A61P 27/02 (2006.01); A61P 37/02 (2006.01); A61P 1/16 (2006.01); A61P 19/02 (2006.01); A61P 13/12 (2006.01); A61P 29/00 (2006.01); A61K 31/519 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4439 (2013.01); A61K 31/519 (2013.01); A61K 45/06 (2013.01); A61P 1/16 (2018.01); A61P 13/12 (2018.01); A61P 19/00 (2018.01); A61P 19/02 (2018.01); A61P 27/02 (2018.01); A61P 29/00 (2018.01); A61P 35/00 (2018.01); A61P 37/02 (2018.01); C07D 401/12 (2013.01);
Abstract
Described herein is the use of a LOXL2 inhibitor in the treatment or prevention of conditions, diseases, or disorders associated with LOXL2 activity.